Can inhalations of hyaluronidase be used in acute respiratory distress-syndrome in patients with COVID-19?

Abstract

Hyaluronidase is currently not included into Russian or foreign guidelines on the treatment of acute respiratory distress-syndrome in patients with COVID-19, and such treatment is not supported by evidence of clinical effectiveness. Hyaluronidase can only be used for COVID-19 within clinical trials.

Keywords

• коронавирус
• гиалуронидаза
• острый респираторный дистресс-синдром
• covid-19